Johns Hopkins ABX Guide
Lopinavir/ritonavir
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretrovirals in adults and pediatric patients (14 days and older).
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 10, 2023
Citation
Auwaerter, Paul G, and Paul A Pham. "Lopinavir/ritonavir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2023. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540322/all/Lopinavir_ritonavir.
Auwaerter PG, Pham PA. Lopinavir/ritonavir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2023. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540322/all/Lopinavir_ritonavir. Accessed December 18, 2024.
Auwaerter, P. G., & Pham, P. A. (2023). Lopinavir/ritonavir. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540322/all/Lopinavir_ritonavir
Auwaerter PG, Pham PA. Lopinavir/ritonavir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2023. [cited 2024 December 18]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540322/all/Lopinavir_ritonavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lopinavir/ritonavir
ID - 540322
A1 - Auwaerter,Paul,M.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2023/09/10/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540322/all/Lopinavir_ritonavir
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
